The Boston Bruins' 2026-27 regular season draws nearer, and with it, the future of Pavel Zacha remains a mystery.

Incyte Corporation is a profitable, cash-generating biotech with a robust pipeline and a core revenue driver in Jakafi. Read ...

It’s been a few days since the Robinhood Chain’s launch, and its memecoins are exploding. A top-performing token is Cash Cat ...

Molina Healthcare is rated Hold as its stock fully prices in a 2027 recovery, with no clear upside or downside at $225.

Samsung Biologics has agreed to acquire a leading global peptide contract development and manufacturing organization in a ...

Beneath an exploding sky, illuminated by a bombardment of fireworks, the National League's most unlikely All-Star jogged in ...

Two mega-caps reported blockbuster spring quarters, yet their stocks split hard this summer. Meta Platforms (NASDAQ: META) ...

An Icelandic billionaire has become the latest wealthy business leader to quit Britain since Labour came to power.

Discover how leveraged ETFs are fueling the AI rally and impacting market volatility, particularly in South Korea's ...

Residents nearby were evacuated during the incident ...

Exchange-traded funds have been a fixture of financial markets since the 1990s as a popular low-cost way for investors to buy ...

Hyperscaler giants are hemorrhaging cash while two chip names absorb every dollar they spend, but only one of those ...